Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Association of peripheral arterial and cardiovascular diseases in familial hypercholesterolemia.

Pereira C, Miname M, Makdisse M, Kalil Filho R, Santos RD.

Arq Bras Cardiol. 2014 Aug;103(2):118-23. Epub 2014 Jul 15. English, Portuguese.

2.

Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.

Tamura K, Tsurumi-Ikeya Y, Wakui H, Maeda A, Ohsawa M, Azushima K, Kanaoka T, Uneda K, Haku S, Azuma K, Mitsuhashi H, Tamura N, Toya Y, Tokita Y, Kokuho T, Umemura S.

Ther Apher Dial. 2013 Apr;17(2):185-92. doi: 10.1111/j.1744-9987.2012.01149.x. Epub 2012 Dec 7. Review.

PMID:
23551675
3.

A critical review on the use of lipid apheresis and rheopheresis for treatment of peripheral arterial disease and the diabetic foot syndrome.

Weiss N.

Semin Dial. 2012 Mar-Apr;25(2):220-7. doi: 10.1111/j.1525-139X.2011.01036.x. Epub 2011 Dec 16. Review.

PMID:
22175277
4.

Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease.

Endo M, Kumakura H, Kanai H, Araki Y, Kasama S, Sumino H, Ichikawa S, Kurabayashi M.

Hypertens Res. 2010 Sep;33(9):911-5. doi: 10.1038/hr.2010.93. Epub 2010 Jun 10.

PMID:
20535117
5.

Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.

Athyros VG, Tziomalos K, Kakafika AI, Koumaras H, Karagiannis A, Mikhailidis DP.

Am J Cardiol. 2008 Feb 15;101(4):483-5. doi: 10.1016/j.amjcard.2007.09.096. Epub 2007 Dec 20.

PMID:
18312762
6.

A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.

Unno N, Sakaguchi T, Nakamura T, Yamamoto N, Sugatani J, Miwa M, Konno H.

J Surg Res. 2006 Jul;134(1):36-43. Epub 2006 May 2.

PMID:
16650870
7.

Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index.

Aso Y, Okumura K, Wakabayashi S, Takebayashi K, Taki S, Inukai T.

J Clin Endocrinol Metab. 2004 Nov;89(11):5713-7.

PMID:
15531533
8.

Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease.

Blessing F, Wang Y, Walli AK, Seidel D.

Transfus Apher Sci. 2004 Jun;30(3):255-66. Review.

PMID:
15172631
9.

Low-density lipoprotein apheresis in the treatment of peripheral arterial disease.

Kawashima A.

Ther Apher Dial. 2003 Aug;7(4):413-8. Review.

PMID:
12887724
11.

How does ascorbic acid prevent endothelial dysfunction?

May JM.

Free Radic Biol Med. 2000 May 1;28(9):1421-9. Review.

PMID:
10924860
12.
14.

The prevalence of peripheral vascular disease in familial hypercholesterolaemia.

Kroon AA, Ajubi N, van Asten WN, Stalenhoef AF.

J Intern Med. 1995 Nov;238(5):451-9.

PMID:
7595185
15.

[Highly sensitive apo B assay and its clinical significance].

Harano Y.

Rinsho Byori. 1990 Aug;38(8):861-7. Japanese.

PMID:
2232245

Supplemental Content

Loading ...
Support Center